PAUL RICHARDS, M.D.
Hematology & Oncology Physician in SALEM, Virginia. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.
What the federal data shows
PAUL RICHARDS, M.D. reported a CMS MIPS final score of 83.9724/100 — above the 83.1 national average — and filed 384 Medicare Part D claims in 2023.
- 83.9724/100
- MIPS score · +1 vs avg
- 384
- Part D claims, 2023
- 71%
- generic prescribing
- Likely
- board-certified (heuristic)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.
PAUL RICHARDS, M.D.'s MIPS score vs every scored U.S. clinician
CMS Merit-based Incentive Payment System (MIPS) final score, 2023 — the federal quality measure
84 42nd percentile higher than 42% of 477,587 scored providers
Each bar is a band; taller bars hold more scored providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source CMS Merit-based Incentive Payment System (MIPS) · 2023
PAUL RICHARDS, M.D. practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about PAUL RICHARDS, M.D.?
Near national averagePrimary specialty
Medicare Part D claims
MIPS final score
Specialty distribution in Virginia
How Hematology & Oncology Physician compares to other specialties among Virginia providers
Hematology & Oncology Physician share within Virginia
Hematology & Oncology Physician is one of the more visible NUCC categories in Virginia
Each bar reflects the share of in-state providers whose primary NUCC taxonomy matches the specialty. Long tail of ~690 NUCC codes folded into "Other" to keep the comparison legible.
Medicare quality performance — MIPS
PAUL RICHARDS, M.D.'s 2023 MIPS final score plotted against the Hematology & Oncology Physician national average
- MIPS Final Score
- 83.9724/100
- vs 83.1 national avg · 2023 performance year
MIPS final score (Hematology & Oncology Physician) — 83.9724/100 vs national avg 83.1
Quality benchmarks
- National MIPS avg 2023 reporting year
- Quality dim CMS Quality category
- Cost dim CMS Cost category
- Specialty volume Hematology & Oncology Physician US NPIs
83.9724/100 MIPS final score — 0.9 pts above the 83.1 national average
Quality, Cost, Promoting Interoperability, and Improvement Activities composite score for the 2023 performance year. Specialty: Hematology & Oncology Physician. Quality dim: 73.8008. Cost dim: 57.1654.
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
PAUL RICHARDS, M.D. appears in the CMS NPPES registry as a Hematology & Oncology Physician provider holding M.D. credentials at 1900 ELECTRIC RD, SALEM, VA, 24153, with a listed phone of (540) 774-8660. NPI 1053387266 was issued on 02/27/2006. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what RICHARDS most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.
Medicare Part D records for calendar year 2023 show 384 prescription claims written by this provider, covering 112 Medicare beneficiaries and totaling roughly $823K in drug spend, split 29% brand-name and 71% generic by claim count, with an opioid prescribing rate of 3.6%. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 83.9724/100 for the 2023 performance year (Quality 73.8008, Cost 57.1654), compared with the national average of 83.1.
Hematology & Oncology Physician is a mid-sized specialty nationwide, with 11,215 enrolled providers across 54 states and an average of 847 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.
Practice Address
Provider Details
| NPI | 1053387266 |
|---|---|
| Specialty | Hematology & Oncology Physician |
| Credentials | M.D. |
| Gender | Male |
| NPI Issued | 02/27/2006 |
Verify this provider's license
PlainDoctor pulls this profile from the CMS NPPES public registry. Confirm PAUL RICHARDS, M.D.'s current license status, disciplinary history, and board certifications with the Virginia Board of Medicine in Virginia before relying on this page for a clinical or care decision.
How we sourced this profile
CMS Quality Score (MIPS)
Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.
Reporting: Group practice
Brand vs generic prescribing mix · Above average
29% brand-name claims vs 71% generic, on 384 2023 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2023.
Prescribing Breakdown
- 30-Day Fills
- 699
- Total Day Supply
- 20,440
- Brand vs Generic
- 29% brand / 71% generic
- Brand Drug Cost
- $815K
- Generic Drug Cost
- $8K
- Opioid Claims
- 14 (3.6% rate)
Patient Demographics
- Average Patient Age
- 72.9 years
- Avg HCC Risk Score
- 2.02
- Gender Split
- 71% female / 29% male
- Age Distribution
- <65: 11, 65-74: 55, 75-84: 32, 85+: 14
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.
What PAUL RICHARDS, M.D. prescribes most
Top Medicare Part D drugs by claim count, 2023
- Letrozole
Letrozole
47 claims
- Eliquis
Eliquis
42 claims
- Hydroxyurea
Hydroxyurea
26 claims
- Jakafi 16
Jakafi
16 claims
- Ibrance 14
Ibrance
14 claims
- Escitalopram Oxalate 13
Escitalopram Oxalate
13 claims
- Ondansetron Hcl 13
Ondansetron Hcl
13 claims
- Tamoxifen Citrate 12
Tamoxifen Citrate
12 claims
| Drug | Claims |
|---|---|
| Letrozole | 47 |
| Eliquis Apixaban | 42 |
| Hydroxyurea | 26 |
| Jakafi Ruxolitinib Phosphate | 16 |
| Ibrance Palbociclib | 14 |
| Escitalopram Oxalate | 13 |
| Ondansetron Hcl | 13 |
| Tamoxifen Citrate | 12 |
| Anastrozole | 11 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Hematology & Oncology Physician Overview
How PAUL RICHARDS, M.D. fits within the Hematology & Oncology Physician landscape nationally.
PAUL RICHARDS, M.D.'s 384 claims are below the specialty average of 847.
Nearby Hematology & Oncology Physician Providers in Virginia
Other clinicians with the same primary specialty enrolled in Virginia, drawn from the same CMS NPPES roster as RICHARDS.
Compare Hematology & Oncology Physician nationally: see state-by-state distribution →
Healthcare Guides
Learn more about finding, verifying, and understanding healthcare providers.
Explore Virginia
Frequently Asked Questions
What is PAUL RICHARDS, M.D.'s specialty? ▼
How much does PAUL RICHARDS, M.D. prescribe under Medicare Part D? ▼
What is PAUL RICHARDS, M.D.'s Medicare quality score? ▼
Where is PAUL RICHARDS, M.D. located? ▼
What is PAUL RICHARDS, M.D.'s NPI number? ▼
Does PAUL RICHARDS, M.D. prescribe more brand-name or generic drugs? ▼
Does PAUL RICHARDS, M.D. prescribe opioids? ▼
How many Hematology & Oncology Physician providers are there in the US? ▼
What drugs does PAUL RICHARDS, M.D. prescribe most often? ▼
Does PAUL RICHARDS, M.D. accept Medicare? ▼
How can I verify PAUL RICHARDS, M.D.'s credentials? ▼
Data Sources
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Quality Performance
- CMS Merit-based Incentive Payment System (MIPS) — 2023 performance year.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology